top of page
New Wave Biotech Dec 2023 Template_edited.jpg

De-risking Biomanufacturing:
From Strain Design to Purification

Webinar & Panel Discussion

Webinar - De-risking Biomanufacturing - 16_9 form banner light.png

​Upstream and downstream are too often developed in isolation, and that disconnect is where scale-up surprises, rising costs and failed batches tend to appear.

​

​This panel brings together a startup, a scale-up facility and an equipment supplier to discuss how to de-risk bioprocess development end to end, from strain design through to purification. We’ll cover:

  • ​How variability coming out of fermentation affects separation and purification

  • ​What pilot testing can tell you, and where results diverge from industrial production

  • ​The blind spots in process development that most often lead to scale-up surprises

  • ​The role of digital and AI tools in process development and scale-up today

 

​The session is designed for R&D directors, process development leads and anyone taking a bioprocess from lab to industrial scale. It opens with a short introduction from the hosts, followed by the panel discussion and audience Q&A.

​

​Hosts:

  • ​Zoe Yu Tung Law, co-founder and CEO of New Wave Biotech, whose platform, Bioprocess Foresight, uses hybrid AI to predict and optimise how downstream processes perform at scale. It has predicted pilot-scale centrifugation performance with CPI to under 7% error, and helped Multus Biotechnology achieve an 8.6x yield improvement.

  • ​Dr. Rémi Peyraud, co-founder and CEO of iMEAN Biotech, which uses metabolic modelling to help teams design optimised strains and fermentation processes. He holds a PhD from ETH Zürich and spent 10 years in academic research at ETH and INRAE before founding iMEAN.

 

​Panellists:

  • ​Dr. Maya Bendifallah, co-founder and CSO of Nutropy, a startup developing animal-free dairy using precision fermentation. She has worked in precision fermentation for 15 years across the United States and France, holds a PhD from Université Paris-Saclay, and has carried out research with French public institutes including the CNRS and CEA. She built and now leads Nutropy’s scientific team and strategy.

  • ​Dr.-Ing. Jan-Niklas Denker, Director Pilot Testing at GEA’s Process Test Center. He leads pilot testing for separation processes, supporting the transfer of test results and process concepts from pilot scale to industrial applications.

  • ​Dr. Khadidja Romari, President and CEO of Biotech Open Platform, with over 25 years of experience in industrial biotechnology, fermentation process development and scale-up. Her expertise lies in bridging laboratory innovation and industrial manufacturing, with a strong focus on process performance, scalability and downstream processing.

Want to scale to market quicker and cheaper? 

Dynamically model your process, understand the techno economics and optimise with our AI-powered Bioprocess Simulation platform.

bottom of page